JBIO vs RLAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 24, 2026

JBIO

45.4
AI Score
VS
RLAY Wins

RLAY

52.6
AI Score

Investment Advisor Scores

JBIO

45score
Recommendation
HOLD

RLAY

53score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric JBIO RLAY Winner
Net Income -96.13M -276.48M JBIO
Operating Income -102.36M -302.74M JBIO
ROE -21.9% -48.8% JBIO
ROA -20.4% -44.5% JBIO
Total Assets 472.11M 621.33M RLAY
Cash 107.25M 84.02M JBIO
Current Ratio 14.93 22.61 RLAY
Free Cash Flow -67.93M -235.87M JBIO

Relative Price Performance (Last 90 Days)

JBIO 1M: -1.0% · 3M: -26.9% RLAY 1M: +2.5% · 3M: -2.5%

Current Technical Phase

JBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -13.5%), weak momentum, RSI 45

RSI (14): 44.9 · Price: $14.59

RLAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.5 · Price: $18.18

Fundamentals Snapshot

Metric JBIO RLAY
Market Cap — —
Forward P/E -5.5 -11.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -0.5%
Gross Margin — -25.0%
Operating Margin 0.0% -259.5%
EPS -1.92 -1.56
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, RLAY is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.